CORNWALL 2019

 

Freedom of Information Team

Suite 6,Carew House

Beacon Technology Park

Dunmere Road

Bodmin

Cornwall

PL31 2QN

 

Tel: 01208 834496

Email:cpn-tr.FreedomOfInformation@NHS.net

Thank you for your request for information as detailed below, together with our reply.    

                                                                              

You asked us:

Our reply:

Please provide ECT information under the FOI act to the following questions: -

 Please supply patient’s information ECT leaflet.  

 

Please supply patient ECT consent form.

 

 

Please supply any ECT reports/investigations

 

 

How many ECT in 2019?

 

What proportion of patients were men/women?  

 

How old were they?

What were the diagnoses and in what proportions?  

 

 

 The patient information document on ECT provided is based on the document produced by the Royal College of Psychiatrists. Please refer to that document

The consent form used is the standard form issued by the Department of Health. Please refer to that document.

 

We are exempt from providing this information in accordance with section 40 of the Freedom of Information Act (FOI); as releasing any internal investigation reports will contain information and will make individuals personally identifiable.

 

22 new patients

 

12 – women, 10 – men

 Ages ranged from 35 – 85

 

20 severe depression 2 Catatonia

 

.

 

                       

 

 

  1. What proportion of patients were classified BAME?

How many were receiving ECT for the first time?

How many patients consented to ECT?

How many ECT complaints were investigated outside the NHS and CCG?

 

How many patients died during or soon after ECT and what was the cause (whether or not ECT was considered the cause)?

 

How many patients died a few months after ECT and what was the cause (whether or not ECT was considered the cause)?

 

 

How many patients died by suicide within a few months of receiving ECT (whether or not ECT was considered the cause)?

How many patients have suffered complications during and after ECT and what were those complications?

Have there been any formal complaints from patients/relatives about ECT?

If so, what was their concerns?

 

 

 

 

 

How many patients report memory loss/loss of cognitive function?

 

 

What tests are used to assess memory loss/loss of cognitive function?

Have MRI or CT scans been used before and after ECT?

 

  1. None

 10

 17

 None

 

 The Coroner determines how an individual has died, therefore, the Trust is not always made aware of the outcome of an inquest.

 We are exempt from providing this information in accordance with section 40 of the Freedom of Information Act (FOI) where to reveal a low number of patient information could make the individuals personally identifiable, therefore breaching patient confidentiality.

 

None

 

 None

Yes

 

We are exempt from providing this information in accordance with section 40 of the Freedom of Information Act (FOI) where to reveal a low number of patient information could make the individuals personally identifiable, therefore breaching patient confidentiality.

 

We are exempt from providing this information in accordance with section 40 of the Freedom of Information Act (FOI) where to reveal a low number of patient information could make the individuals personally identifiable, therefore breaching patient confidentiality.

 

Abbreviated Mental Test. Self-reporting memory scale

 

Not as a routine procedure

 

 

 

  1. If so what was the conclusion?

 How does the Trust plan to prevent ECT in the future?

 

Please provide SERIOUS INCIDENT information under the FOI act to the following questions: -

Please supply SERIOUS INCIDENT REPORTS patient’s information leaflet.

 

Please supply patient SERIOUS INCIDENT REPORTS consent form.

  

 

 

Please supply any serious incident reports/investigations

 

 

How many SERIOUS INCIDENT REPORTS in 2019?

 

 

What proportion of patients were men/women?

 

 

 

How old were they?  

 

What were the diagnoses and in what proportions?

 

 

What proportion of patients were classified BAME?

 

How many were receiving SERIOUS INCIDENT REPORTS for the first time?

 

How many patients consented to SERIOUS INCIDENT REPORTS?

 

How many SERIOUS INCIDENT REPORTS were investigated outside the NHS and CCG?

How many patients died during or soon after

SERIOUS INCIDENT REPORTS and what was the cause (whether or not SERIOUS INCIDENT REPORTS was considered the cause)?

  1. Not applicable

 It does not plan to prevent ECT

 

 

 

We do not hold a patient information leaflet, as the process is explained through duty of candour.

 

Serious incident reviews are part of internal organisational learning and we do not require patient consent to review the care and treatment that we provide.

 

We are exempt from providing this information in accordance with section 40 of the Freedom of Information Act (FOI); as releasing any internal investigation reports will contain information and will make individuals personally identifiable.

 

between 01/04/2019 to 31/03/2020 there were 90 serious incident investigations.

 

44% female

52% male

4% unspecified

 

We are unable to provide this data at

patient level

We are unable to provide this data at

patient level

 

Of the 90 cases where ethnicity was stated

1% were classified as BAME

We do not hold this data in reportable format.

 

 

We do not need patient consent to undertake a SI investigation.

 We do not hold this data

 

We do not provide patient level data

 

 

 

 

How many patients died a few months after

SERIOUS INCIDENT REPORTS and what was the cause (whether or not SERIOUS INCIDENT REPORTS was considered the cause)?

How many patients died by suicide within a few months of receiving SERIOUS INCIDENT REPORTS (whether or not SERIOUS INCIDENT REPORTS was considered the cause)?

How many patients have suffered complications during and after SERIOUS INCIDENT REPORTS and what were those complications?

Have there been any formal complaints from patients/relatives about SERIOUS INCIDENT REPORTS?

If so, what was their concerns?

How many patients report memory loss/loss of cognitive function?

What tests are used to assess memory loss/loss of cognitive function?

Have MRI or CT scans been used before and after SERIOUS INCIDENT REPORTS?

 

If so what was the conclusion?

 

How does the Trust plan to prevent SERIOUS INCIDENTS in the future?

 

 

Please provide restraints information under the

FOI act to the following questions: -

Please supply RESTRAINTS patient’s information leaflet.

 

Please supply patient RESTRAINTS consent form.

 

Please supply any Restraints/investigations

 

 

 

How many RESTRAINTS in 2019?

 

What proportion of patients were men/women?

 

We do not provide patient level data

 

 

We do not provide patient level data

 

We do not provide patient level data

 

None

Not applicable

We do not hold this data in reportable format.

 

Addenbrooke’s Cognitive Examination

 

We do not hold this data in reportable format.

 

Not applicable

 

Yes the Trust has an incident and reporting policy where the focus is learning from incidents.,

 

 

 

 

Please see the attached Restraint Leaflet

 

We do not have a Restraint consent form

 

We are exempt from providing this information in accordance with section 40 of the Freedom of Information Act (FOI); as releasing any internal investigation reports will contain information and will make individuals personally identifiable.

 

715

 

56% Female 44% Male

 

 

  1. How old were they?  

What were the diagnoses and in what proportions?

 

What proportion of patients were classified BAME?

 

How many were receiving RESTRAINTS for the first time?

How many patients consented to RESTRAINTS?

 

How many RESTRAINTS were investigated outside the NHS and CCG ?

How many patients died during or soon after RESTRAINTS and what was the cause (whether or not RESTRAINTS was considered the cause)?

How many patients died a few months after RESTRAINTS and what was the cause (whether or not RESTRAINTS was considered the cause)?

How many patients died by suicide within a few months of receiving RESTRAINTS (whether or not RESTRAINTS was considered the cause)?

How many patients have suffered complications during and after RESTRAINTS and what were those complications?

Have there been any formal complaints from patients/relatives about RESTRAINTS?

If so, what was their concerns?

 

How many patients report memory loss/loss of cognitive function?

 

What tests are used to assess memory loss/loss of cognitive function?

Have MRI or CT scans been used before and after RESTRAINTS?

 

If so what was the conclusion?

 

How does the Trust plan to reduce restraints in the future?

As we aren’t able to provide data at patient level can only supply average age which is 40

 Data not recorded on incident system

 

 

Of the 476 where ethnicity stated 6.93% from BAME community

 

We do not hold this information in a reportable format

We do not hold this information in a reportable format

 

We do not hold this information in a reportable format

We do not hold this information in a reportable format

 

We do not hold this information in a reportable format

 

We do not hold this information in a reportable format

 

We do not hold this information in a reportable format

 

We do not hold this information in a reportable format

We do not hold this information in a reportable format

 

 

We do not hold this information in a reportable format

 

We do not hold this information in a reportable format

 

We do not hold this information in a reportable format

 

We do not hold this information in a reportable format

 

The trust promotes trauma informed care and how this will enable the creation of

 

 

 

 

Please provide SECLUSION information under the FOI act to the following questions: -

Please supply patient’s information SECLUSION leaflet.

Please supply patient SECLUSION consent form.

Please supply any SECLUSION

reports/investigations  

 

How many SECLUSION in 2019?

What proportion of patients were men/women?

How old were they?  

 

 

What were the diagnoses and in what proportions?

 

What proportion of patients were classified BAME?

 

How many were receiving SECLUSION for the first time?

 

How many patients consented to SECLUSION?

 

How many SECLUSIONS were investigated outside the NHS and CCG ?

 

How many patients died during or soon after SECLUSION and what was the cause (whether or not SECLUSION was considered the cause)?

How many patients died a few months after SECLUSION and what was the cause (whether or not SECLUSION was considered the cause)?

How many patients died by suicide within a few months of receiving SECLUSION (whether or not SECLUSION was considered the cause)?

individualised, least restrictive interventions. Learning from experience aids the development of staff understanding proactive measures to avoid a restraint occurring.

 

 

We do not have a Seclusion leaflet.

We do not have a Seclusion consent form

We are exempt from providing this information in accordance with section 40 of the Freedom of Information Act (FOI); as releasing any internal investigation reports will contain information and will make individuals personally identifiable.

78

Female 29% Male 71%

As we aren’t able to provide data at patient level can only supply average age which is 32

 

 

We do not hold this information in a reportable format

 

3.85%

 

We do not hold this information in a reportable format

 

We do not hold this information in a reportable format

 

We do not hold this information in a reportable format

 

We do not hold this information in a reportable format

 

We do not hold this information in a reportable format

 

 

We do not hold this information in a reportable format

 

 

How many patients have suffered complications during and after SECLUSION and what were those complications?

Have there been any formal complaints from patients/relatives about SECLUSION?

If so, what was their concerns?

    

How many patients report memory loss/loss of cognitive function?

What tests are used to assess memory loss/loss of cognitive function?

Have MRI or CT scans been used before and after SECLUSION?

 

If so what was the conclusion?

 

How does the Trust plan to prevent SECLUSION in the future?

 

 

 

 

Please provide MEDICATION ERRORS information under the FOI act to the following questions: -

Please supply patient’s information MEDICATION ERRORS leaflet.

Please supply patient MEDICATION ERRORS consent form.

Please supply any MEDICATION ERRORS

reports/investigations  

 

 

How many MEDICATION ERRORS in 2019?

 

What proportion of patients were men/women?

 

How old were they?  

 

 

 

We do not hold this information in a reportable format

 

We do not hold this information in a reportable format

We do not hold this information in a reportable format

 

We do not hold this information in a reportable format

 

We do not hold this information in a reportable format

 

We do not hold this information in a reportable format

We do not hold this information in a reportable format

 

The trust adopts a least restrictive practice approach when it comes to delivering care. Staff utilise proactive measures to avoid the use of seclusion where possible. Using positive behaviour support staff can identify triggers and put measures in place to help support the individual in crisis.

 

 

 

We do not have a Medication Error leaflet.

 

We do not have a Medication Error consent form.

We are exempt from providing this information in accordance with section 40 of the Freedom of Information Act (FOI); as releasing any internal investigation reports will contain information and will make individuals personally identifiable.

 

1396

 

Female 51% Male 49%

As we aren’t able to provide data at patient level can only supply average age which is 61

 

  1. What were the diagnoses and in what proportions?

 

What proportion of patients were classified BAME?

 

How many were receiving MEDICATION ERRORS for the first time?

 

How many patients consented to MEDICATION ERRORS?

 

How many MEDICATION ERRORS S were investigated outside the NHS and CCG?

How many patients died during or soon after

MEDICATION ERRORS and what was the cause (whether or not MEDICATION ERRORS was considered the cause)?  

How many patients died a few months after

MEDICATION ERRORS and what was the cause (whether or not MEDICATION ERRORS was considered the cause)?  

How many patients died by suicide within a few months of receiving MEDICATION ERRORS (whether or not MEDICATION ERRORS was considered the cause)?

How many patients have suffered complications during and after MEDICATION ERRORS and what were those complications?

Have there been any formal complaints from patients/relatives about MEDICATION ERRORS?  

If so, what was their concerns?

How many patients report memory loss/loss of cognitive function?

What tests are used to assess memory loss/loss of cognitive function?

Have MRI or CT scans been used before and after MEDICATION ERRORS?

 

If so what was the conclusion?

 

How does the Trust plan to prevent

MEDICATION ERRORS in the future?

  1. We do not hold this information in a reportable format

 

4.6%

 

We do not hold this information in a reportable format

 

We do not hold this information in a reportable format

 

We do not hold this information in a reportable format

 

We do not hold this information in a reportable format

 

 

We do not hold this information in a reportable format

 

We do not hold this information in a reportable format

 

We do not hold this information in a reportable format

 

We do not hold this information in a reportable format

We do not hold this information in a reportable format

We do not hold this information in a reportable format

We do not hold this information in a reportable format

We do not hold this information in a reportable format

We do not hold this information in a reportable format

 

 

We do not hold this information in a reportable format

 

If you have any further queries, please contact me.

 

The information supplied to you continues to be protected by the Copyright, Designs and Patents Act 1988. You are free to use it for your own purposes, including any non-commercial research you are doing and for the purposes of news reporting. Any other re-use, for example commercial publication, would require the permission of the copyright holder. Most documents supplied by Cornwall Partnership NHS Foundation Trust will have been produced by local officials and will be our copyright. Information you receive which is not subject to our copyright continues to be protected by the copyright of the person, or organisation, from which the information originated. You must ensure that you gain their permission before reproducing any third party information.

 

If you are not satisfied with the response to your request you have the right to an internal review. The handling of your request will be looked at by someone who was not responsible for the original case and they will make a decision as to whether your request was managed correctly.

 

If you would like to request a review please write to:

 

                      Piers Margetts

Head of Information Governance

                      Cornwall Partnership NHS Foundation Trust

Suite 6, Carew House

Beacon Technology Park

Dunmere Road

Bodmin

Cornwall

PL31 2QN

 

If you remain dissatisfied, after an internal review decision, you have the right to apply to the Information Commissioner’s Office. The Commissioner is an independent regulator who has the power to direct the Trust to respond to your request differently, if it is considered that your request was handled incorrectly.

 

You can contact the Information Commissioners Office at the following address:

 

Information Commissioners Office

Wycliffe House

Water Lane

Wilmslow

Cheshire

SK9 5AF

 

The Trust continually strives to provide the best possible service to people who request information using the Freedom of Information Act 2000 legislation. To help achieve this, the Trust would be most grateful if you would complete, and return, the attached Applicant Satisfaction Survey form.

 

Yours sincerely

 

 

Michelle McLeavy

Interim Associate Director of Quality and Governance